The U.S. Food and Drug Administration (FDA) has accepted a new drug application for gedatolisib in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA ...
Financial applications, ranging from mobile banking apps to payment gateways, are among the most targeted systems worldwide.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果